Leadership

Meet our leadership team.

The leaps we're helping to deliver in research and innovation that inform better patient outcomes wouldn't be possible without our deep partnerships with researchers and clinicians across all sectors of the healthcare landscape — including academic and community institutions, industry, and patient advocacy organizations.

QLHC Operations

The clinical trial operational leadership who make our platform trials possible.

Daniel Dornbusch

Chief Executive Officer

Adam Asare

Chief Data Officer

Pinaki Chakraborty

VP, Quality Assurance

Sara Horton

Strategic Clinical Trials Access and Partnerships, Lead

Smita Asare

Executive Director, I-SPY Phase 1

Paul Henderson

Senior Director, Collaborations

Maria Pitsiouni

Senior Director, Clinical Operations Oncology

Muhammed Salem

Director, Clinical Safety

Jasmine LaCoursiere

VP, Recruitment Tool and Clinical Data Transformation

Eva Yuen

Vice President, Finance & Accounting/ Controller

Florence Chu

Director, Clinical Pharmacy Affairs & Drug Management

Brendan Raven

Senior Legal Counsel

Wiebke Raven

Director of Grants

Susan Heusbourg

Director, Clinical Monitoring

Mina Koriakos

Financial Analytics Manager, Clinical Operations

Board of Directors

QLHC Board of Directors

Guiding our mission with decades of leadership across medicine, research, finance, and law.

Laura Esserman

MD, MBA | Cofounder

Dave Mandelkern

MS

Robyn Lawrie Rutledge

MBA | Chairman of the Board

Anna Barker

PhD

Lucas de Breed

PhD, MBA

Dorian Daley

Esq

Susan Foley

CFA

Keir Loiacono

Esq

Michele Markus

Board Member

Gregory C. Simon

Board Member

Mark Simon

MBA

N. Marcus Thygeson

MD, MPH

Lambert van der Walde

MBA

Janet Woodcock

MD

Jeffrey Pfeffer

MD, MBA | Cofounder | Emeritus

Robert Patterson

Esq | Cofounder | Emeritus